Vol 94, No 3 (2023)
Research paper
Published online: 2022-08-22

open access

Page views 2504
Article views/downloads 645
Get Citation

Connect on Social Media

Connect on Social Media

Our clinical experience in pelvic magnetic resonance imaging with vaginal contrast

Fatma Öztürk Keleş1, Inan Korkmaz1, Esin Dogan2, Sibel Hakverdi2, Kenan Dolapcioglu3, Sinem Karazincir1
Pubmed: 35997217
Ginekol Pol 2023;94(3):198-202.

Abstract

Objectives: Magnetic resonance imaging (MRI) is an important modality for pelvic imaging. Vaginal distension is provided by the use of vaginal contrast in pelvic MRI, and it plays an important role in staging especially cervical and vaginal cancer. The aim of this study is to show whether the use of vaginal contrast material contributes to the diagnosis in pelvic examination.

Material and methods: Between October 1, 2016 and December 30, 2020, a total of 57 patients who underwent pelvic magnetic resonance imaging with vaginal contrast in the radiology clinic were included in the study and evaluated retrospectively.

Results: Cervical cancer was detected in 38 of the 57 patients included in the study, and when the vaginal pre- and post-contrast staging of the patients was performed, the pre-contrast stage was found to be high in six patients (15%). Eight of 38 patients diagnosed with cervical cancer underwent surgery. When the pathological and radiological staging of the patients who underwent surgery were compared, they were 100% compatible.

Conclusions: The use of vaginal contrast material increases the diagnostic value of MRI in various pelvic pathologies, especially in cervical cancer staging.

Article available in PDF format

View PDF Download PDF file

References

  1. Akata D, Kerimoglu U, Hazirolan T, et al. Efficacy of transvaginal contrast-enhanced MRI in the early staging of cervical carcinoma. Eur Radiol. 2005; 15(8): 1727–1733.
  2. Van Hoe L, Vanbeckevoort D, Oyen R, et al. Cervical carcinoma: optimized local staging with intravaginal contrast-enhanced MR imaging--preliminary results. Radiology. 1999; 213(2): 608–611.
  3. Young P, Daniel B, Sommer G, et al. Intravaginal gel for staging of female pelvic cancers--preliminary report of safety, distention, and gel-mucosal contrast during magnetic resonance examination. J Comput Assist Tomogr. 2012; 36(2): 253–256.
  4. Atcı N, Özgür T, Öztürk F, et al. Utility of intravaginal ultrasound gel for local staging of cervical carcinoma on MRI. Clin Imaging. 2016; 40(6): 1104–1107.
  5. Shaker SS, Al Sa. Study of pathologic stages of cancer cervix by using MRI with or without intravaginal gel. Al-Alzhar Assiut Med J. 2010; 8: 30.
  6. Fiaschetti V, Crusco S, Meschini A, et al. Deeply infiltrating endometriosis: evaluation of retro-cervical space on MRI after vaginal opacification. Eur J Radiol. 2012; 81(11): 3638–3645.
  7. Palmucci S, Piccoli M, Piana S, et al. Diffusion MRI for rectal cancer staging: ADC measurements before and after ultrasonographic gel lumen distension. Eur J Radiol. 2017; 86: 119–126.
  8. Hong JH, Jung UnS, Min KJ, et al. Prognostic value of total lesion glycolysis measured by 18F-FDG PET/CT in patients with locally advanced cervical cancer. Nucl Med Commun. 2016; 37(8): 843–848.
  9. Bhatla N, Aoki D, Sharma DN, et al. Cancer of the cervix uteri. Int J Gynaecol Obstet. 2018; 143 Suppl 2: 22–36.
  10. Bhatla N, Berek JS, Cuello Fredes M, et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet. 2019; 145(1): 129–135.
  11. Mansoori B, Khatri G, Rivera-Colón G, et al. Multimodality Imaging of Uterine Cervical Malignancies. AJR Am J Roentgenol. 2020; 215(2): 292–304.
  12. Thomsen HS. Guidelines for contrast media from the European Society of Urogenital Radiology. AJR Am J Roentgenol. 2003; 181(6): 1463–1471.
  13. Sala E, Wakely S, Senior E, et al. MRI of malignant neoplasms of the uterine corpus and cervix. AJR Am J Roentgenol. 2007; 188(6): 1577–1587.
  14. Cohen WN, Seidelmann FE, Bryan PJ. Use of a tampon to enhance vaginal localization in computed tomography. AJR Am J Roentgenol. 1977; 128(6): 1064–1065.
  15. Unlu E, Virarkar M, Rao S, et al. Assessment of the Effectiveness of the Vaginal Contrast Media in Magnetic Resonance Imaging for Detection of Pelvic Pathologies: A Meta-analysis. J Comput Assist Tomogr. 2020; 44(3): 436–442.
  16. Song G, Sun H, Chen Xu, et al. The Effect of Rectal Distention on the Intravoxel Incoherent Motion Parameters: Using Sonography Transmission Gel. J Comput Assist Tomogr. 2020; 44(5): 759–765.
  17. El Sayed RF, Alt CD, Maccioni F, et al. ESUR and ESGAR Pelvic Floor Working Group. Magnetic resonance imaging of pelvic floor dysfunction - joint recommendations of the ESUR and ESGAR Pelvic Floor Working Group. Eur Radiol. 2017; 27(5): 2067–2085.
  18. Lee LJ, Jhingran A, Kidd E, et al. Acr appropriateness Criteria management of vaginal cancer. Oncology (Williston Park). 2013; 27(11): 1166–1173.